Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine dose comparison as an adjuvant to bupivacaine for suprascapular nerve block in arthroscopic shoulder surgery
PACTR202001596903715Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Menoufia University
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nalbuphine and bupivacaine in postoperative pain (3 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoint: Visual analogue scale pain score. Started Dec 2019; status: recruiting.
02
Drugs
nalbuphinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202001596903715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001596903715.